MedPath

Found 549753 clinical trials

Sort by:

A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer

Not Applicable

Recruiting

Conditions: Solid Tumor Cancer

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT07117461

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Medisys Health Network (Data Collection Only), Richmond Hill, New York, United States

COPD Exacerbation Follow Up

Not yet recruiting

Conditions: COPD (Chronic Obstructive Pulmonary Disease)

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Viz.ai, Inc.

Target Recruit Count: 485

Registration Number: NCT07118306

Root Resorption and Alveolar Bone Changes in the Maxillary Canine Retraction Using Ni Ti Closed-coil Springs Versus Elastomeric Chains (A Split -Mouth Cone Beam CT Study)

Not Applicable

Not yet recruiting

Conditions: Orthodontic Patients Indicated for Upper First Premolar Extraction
Orthodontic Patients Indicated for Maxillary Canine Retraction

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Al-Azhar University

Target Recruit Count: 22

Registration Number: NCT07116954

A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults

Not Applicable

Completed

Conditions: Healthy Adults

Interventions: Drug: PF-07248144

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Pfizer

Target Recruit Count: 24

Registration Number: NCT07117799

Locations: 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States

Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial

Not Applicable

Recruiting

Conditions: Stroke, Ischemic
Cerebral Edema

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Xuanwu Hospital, Beijing

Target Recruit Count: 380

Registration Number: NCT07118345

Locations: 🇨🇳
Xuanwu Hospital, Capital Medical University., Beijing, China
🇨🇳
Liaocheng Brain Hospital, Shandong, China

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

Not Applicable

Not yet recruiting

Conditions: Ocular Graft Versus Host Disease

Interventions: Drug: rhPRG4 450ug/ml
Drug: Vehicle Control

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Lubris Bio Pty Ltd

Target Recruit Count: 15

Registration Number: NCT07118254

Locations: 🇦🇺
Sydney Eye Hospital, Sydney, New South Wales, Australia
🇦🇺
OTA, Brisbane, Queensland, Australia
🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Recruiting

Conditions: Pancreatic Cancer
Intraductal Papillary Mucinous Neoplasm
High-grade Pancreatic Intraepithelial Neoplasia
PDAC - Pancreatic Ductal Adenocarcinoma
Mucinous Cystic Neoplasm

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Changhai Hospital

Target Recruit Count: 400000

Registration Number: NCT07117045

Locations: 🇨🇳
Meinian Onehealth Healthcare Holdings Co., Ltd, Shanghai, Shanghai, China
🇨🇳
Ruici Medical Examination Institution, Shanghai, Shanghai, China
🇨🇳
Changhai Hospital, Shanghai, Shanghai, China

and more 2 locations

Early-Life Strategies for Preventing Obesity in Preschool-aged Children

Not Applicable

Not yet recruiting

Conditions: Childhood Obesity Prevention

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Peking University

Target Recruit Count: 1400

Registration Number: NCT07117149

Locations: 🇨🇳
Department of Maternal and Child Health, School of Public Health, Beijing, Beijing, China

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

Not Applicable

Not yet recruiting

Conditions: Proliferative Diabetic Retinopathy (PDR)

Interventions: Drug: Aflibercept 8mg

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Edward Wood, MD

Target Recruit Count: 40

Registration Number: NCT07118670

Assessing the Feasibility of Coach Mpilo for Men With TB and HIV

Not Applicable

Recruiting

Conditions: Tuberculosis
HIV

First Posted Date: 2025-08-12

Last Posted Date: 2025-08-12

Lead Sponsor: Arizona State University

Target Recruit Count: 240

Registration Number: NCT07117370

Locations: 🇿🇦
Desmond Tutu Health Foundation, East London, South Africa

AI-Powered Research

Premium Access

A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer

COPD Exacerbation Follow Up

Root Resorption and Alveolar Bone Changes in the Maxillary Canine Retraction Using Ni Ti Closed-coil Springs Versus Elastomeric Chains (A Split -Mouth Cone Beam CT Study)

A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults

Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Early-Life Strategies for Preventing Obesity in Preschool-aged Children

High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes

Assessing the Feasibility of Coach Mpilo for Men With TB and HIV

Product

Company

Legal